6 October 2020
The Primary Care Diabetes Society (PCDS)
is pleased to announce
The Primary Care Diabetes Society (PCDS) is pleased to announce this year’s Welsh conference, which will be taking place in a new virtual format.
Organised by the PCDS, the only association solely committed to the needs of primary care diabetes, this virtual conference will examine diabetes care from a Welsh perspective. Through a mixture of lectures and masterclasses, the conference will provide practical guidance to healthcare professionals, focusing on those issues that impact the most on everyday diabetes practice in Wales and beyond.
We are delighted to be delivering an event that we feel provides an invaluable opportunity for us to come together, virtually, and cover the real core issues in day-to-day diabetes care delivery in Wales.
We look forward to welcoming you online.
Welsh Representatives on the PCDS Committee
Sarah Davies, GPwSI Diabetes, Cardiff
Julie Lewis, Nurse Consultant, Primary Care Diabetes, Central Area, North Wales
David Millar-Jones, GP, Cwmbran
Why attend? This fast-paced, interactive conference combines latest clinical guidance, research, case studies and hot topics in diabetes, including lessons learned from COVID-19 and much more
Ask the experts your burning questions through the LIVE Q&A at the end of each session
Log on anytime during the day from the comfort of your own home to view the sessions
Don’t worry if you miss something, all of the content will be available on-demand
Claim 5 CPD points for the full day virtual conference
Agenda
6th October 2020
09.00 - 09.10
Chair’s introduction
David Millar-Jones
09.10 - 09.40
Diabetes in Wales today
- Review of the national picture
- Where are going in Wales?
- What is on the horizon to meet the upcoming challenges?
Julia Platts
15 minute break
09.55 - 10.25
Symposia
15 minute break
10.40 - 11.10
Management of people with COVID-19 and diabetes
- What you need to know about managing diabetes in a COVID world
- How we can continue to offer high-quality care
David Millar-Jones
15 minute break
11.25 - 12.05
‘In Practice’ masterclasses
Rotation 1
1. Emotional wellbeing and engagement
- Psychological issues in diabetes
- Why psychological distress matters
- Resources that primary care clinicians can use now
Rose Stewart
2. Sick day management
- How sickness can interfere with diabetes management
- Some simple tips we can give to our patients
Julie Lewis
3. Frailty and diabetes – deprescribing
- The challenges of frailty
- When should we think about deprescribing
- What de-escalation of care looks like in practice
Clare Hambling
15 minute break
12.20 - 13.00
Rotation 2
1. Emotional wellbeing and engagement
- Psychological issues in diabetes
- Why psychological distress matters
- Resources that primary care clinicians can use now
Rose Stewart
2. Sick day management
- How sickness can interfere with diabetes management
- Some simple tips we can give to our patients
Julie Lewis
3. Frailty and diabetes – deprescribing
- The challenges of frailty
- When should we think about deprescribing
- What de-escalation of care looks like in practice
Clare Hambling
15 minute break
13.15 - 13.45
Shorts:
Kidneys
- How we can best help our patients with kidney disease
Sarah Davies
Heart Failure
- Latest evidence on managing heart failure in diabetes
Richard Chudleigh
15 minute break
14.00 - 14.30
Symposia
15 minute break
14.45 - 15.15
Diabetes distilled
Pam Brown
- Round up of recent research and guidelines relevant to day to day clinical practice
15.15 - 15.25
Chair’s concluding remarks
David Millar-Jones
A full-day virtual conference
6 October 2020 from 9am
Including a LIVE Q&A after every session
Speakers
Pam Brown
Richard Chudleigh
Sarah Davies
GP Partner, Cardiff
Clare Hambling
GP, Norfolk, and Chair of the PCDS
Julie Lewis
Diabetes Lead Nurse, Llandudno
David Millar-Jones
Julia Platts
Consultant Diabetologist and National Clinical Lead for Diabetes in Wales, Cardiff
Rose Stewart
11th Welsh Conference of the Primary Care Diabetes Society
Broadcasting live
Conference
Sponsors
GOLD SPONSOR
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, there were 201 trials at 376 centres in the UK, involving over 7,000 patients. For more information, please visit www.astrazeneca.co.uk
SILVER SPONSOR
Napp Pharmaceuticals Limited
Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We strive to offer new medicines and initiatives that support the NHS in delivering effective, high-quality, sustainable healthcare for the benefit of patients
Masterclass sponsor
Abbott’s Diabetes Care Division
Abbott’s diabetes care division is a global leader in glucose monitoring systems. We are dedicated to helping people manage their diabetes and achieve their best health outcomes with innovative technology, such as the FreeStyle Libre system, allowing patients to monitor their glucose with a quick and easy scan. For more information, such as how the FreeStyle Libre system and our digital health tools support healthcare professionals and their patients visit www.freestylediabetes.co.uk
BRONZE SPONSORS
Boehringer Ingelheim and Lilly Diabetes Alliance
Eli Lilly and Company Ltd
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today, we are building upon this heritage by working to meet the diverse needs of people living with diabetes and those who care for them. Through research and collaboration, a wide range of therapies, and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.co.uk
Novo Nordisk
At Novo Nordisk, our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
Novo Nordisk is a leading global healthcare company, founded in 1923 and our heritage has given us experience and capabilities that enable us to expand access to our medicines and work to prevent and ultimately cure disease by pioneering scientific breakthroughs.
Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 80 countries and markets its products in around 170 countries. Every day, millions of people all over the world rely on our products.
For more information visit novonordisk.co.uk